MELD score, allocation, and distribution in the United States.
作者信息
Wedd Joel P, Harper Ann M, Biggins Scott W
机构信息
Division of Gastroenterology and Hepatology, University of Colorado Denver, Aurora, CO.
United Network for Organ Sharing, Richmond, VA.
出版信息
Clin Liver Dis (Hoboken). 2013 Aug 19;2(4):148-151. doi: 10.1002/cld.233. eCollection 2013 Aug.
Abstract
摘要
相似文献
1
MELD score, allocation, and distribution in the United States.美国的终末期肝病模型（MELD）评分、分配及分布情况
Clin Liver Dis (Hoboken). 2013 Aug 19;2(4):148-151. doi: 10.1002/cld.233. eCollection 2013 Aug.
2
The sickest first? Disparities with model for end-stage liver disease-based organ allocation: one region's experience.先救治病情最重的患者？基于终末期肝病模型的器官分配存在的差异：一个地区的经验。
Liver Transpl. 2003 Nov;9(11):1211-5. doi: 10.1053/jlts.2003.50192.
3
Intraregional model for end-stage liver disease score variation in liver transplantation: Disparity in our own backyard.肝移植中区域性终末期肝病模型评分差异：自家后院的差异。
Liver Transpl. 2018 Apr;24(4):488-496. doi: 10.1002/lt.25021.
4
MELD scores of liver transplant recipients according to size of waiting list: impact of organ allocation and patient outcomes.根据等待名单规模划分的肝移植受者的终末期肝病模型（MELD）评分：器官分配的影响及患者预后
JAMA. 2004 Apr 21;291(15):1871-4. doi: 10.1001/jama.291.15.1871.
5
Impact of the MELD score on waiting time and disease severity in liver transplantation in United States veterans.终末期肝病模型（MELD）评分对美国退伍军人肝移植等待时间和疾病严重程度的影响。
Liver Transpl. 2007 Nov;13(11):1564-9. doi: 10.1002/lt.21262.
6
Short-term postliver transplant survival after the introduction of MELD scores for organ allocation in the United States.在美国引入终末期肝病模型（MELD）评分用于器官分配后肝移植术后的短期生存情况。
Liver Int. 2005 Jun;25(3):536-41. doi: 10.1111/j.1478-3231.2005.01011.x.
7
Higher Mortality in registrants with sudden model for end-stage liver disease increase: Disadvantaged by the current allocation policy.终末期肝病模型突然增加的登记患者中死亡率更高：受当前分配政策不利影响。
Liver Transpl. 2015 May;21(5):683-9. doi: 10.1002/lt.24102. Epub 2015 Apr 1.
8
Model for End-Stage Liver Disease (MELD) score and organ allocation from cadaveric donors for 198 liver transplantation procedures performed in a single center.在一个单一中心进行的198例肝移植手术中，终末期肝病模型（MELD）评分与尸体供体的器官分配情况。
Transplant Proc. 2008 Jul-Aug;40(6):1903-5. doi: 10.1016/j.transproceed.2008.05.016.
9
Geographic Disparities in Liver Allocation and Distribution in the United States: Where Are We Now?美国肝脏分配与分布中的地理差异：我们目前的状况如何？
Transplant Proc. 2019 Dec;51(10):3205-3212. doi: 10.1016/j.transproceed.2019.07.018. Epub 2019 Nov 13.
10
Liver transplantation for hepatocellular carcinoma: impact of the MELD allocation system and predictors of survival.肝细胞癌的肝移植：终末期肝病模型（MELD）分配系统的影响及生存预测因素
Gastroenterology. 2008 May;134(5):1342-51. doi: 10.1053/j.gastro.2008.02.013. Epub 2008 Feb 13.
引用本文的文献
1
Racial and Ethnic Differences in Liver Transplantation and Post-Liver Transplant Survival Among Patients With Hepatocellular Carcinoma.种族和民族差异对肝癌患者肝移植和肝移植后生存的影响。
Cancer Med. 2024 Nov;13(21):e70298. doi: 10.1002/cam4.70298.
2
Inconsistent values and algorithmic fairness: a review of organ allocation priority systems in the United States.不一致的值和算法公平性：美国器官分配优先级系统综述。
BMC Med Ethics. 2024 Oct 17;25(1):115. doi: 10.1186/s12910-024-01116-x.
3
Hepatocellular Carcinoma, Alpha Fetoprotein, and Liver Allocation for Transplantation: Past, Present and Future.肝细胞癌、甲胎蛋白与肝移植供肝分配：过去、现在与未来。
Curr Oncol. 2022 Oct 8;29(10):7537-7551. doi: 10.3390/curroncol29100593.
4
Impact of Model for End-Stage Liver Disease allocation system on outcomes of deceased donor liver transplantation: A single-center experience.终末期肝病分配系统模型对尸体供肝肝移植结局的影响：单中心经验
Ann Hepatobiliary Pancreat Surg. 2021 Aug 31;25(3):336-341. doi: 10.14701/ahbps.2021.25.3.336.
5
Cardiac and Pulmonary Vascular Risk Stratification in Liver Transplantation.心脏和肺部血管风险分层在肝移植中的应用。
Clin Liver Dis. 2021 Feb;25(1):157-177. doi: 10.1016/j.cld.2020.08.008. Epub 2020 Oct 26.
6
Survival Outcomes Are Not Affected When Liver Transplant Surgery Is Done at Night, During Weekends, or Summer Months.在夜间、周末或夏季进行肝移植手术时，生存结果不受影响。
Transplant Direct. 2019 Apr 25;5(5):e449. doi: 10.1097/TXD.0000000000000887. eCollection 2019 May.
7
A simple clinical calculator for assessing cardiac event risk in liver transplant candidates: The cardiovascular risk in orthotopic liver transplantation score.一种用于评估肝移植候选者心脏事件风险的简易临床计算器：原位肝移植中的心血管风险评分
Clin Liver Dis (Hoboken). 2018 Jun;11(6):145-148. doi: 10.1002/cld.718. Epub 2018 Jul 26.
8
Liver Transplantation Update: 2014.《肝脏移植最新进展：2014年》
Euroasian J Hepatogastroenterol. 2015 Jul-Dec;5(2):98-106. doi: 10.5005/jp-journals-10018-1144. Epub 2016 Jul 9.
9
A point-based prediction model for cardiovascular risk in orthotopic liver transplantation: The CAR-OLT score.原位肝移植心血管风险的基于点的预测模型：CAR-OLT评分。
Hepatology. 2017 Dec;66(6):1968-1979. doi: 10.1002/hep.29329. Epub 2017 Nov 6.
10
Same policy, different impact: Center-level effects of share 35 liver allocation.相同政策，不同影响：肝脏分配份额35%的中心层面效应
Liver Transpl. 2017 Jun;23(6):741-750. doi: 10.1002/lt.24769.
本文引用的文献
1
Liver allocation and distribution: possible next steps.肝脏分配与分配：可能的下一步。
Liver Transpl. 2011 Sep;17(9):1005-12. doi: 10.1002/lt.22349.
2
A revised model for end-stage liver disease optimizes prediction of mortality among patients awaiting liver transplantation.终末期肝病模型修订版优化了肝移植等待患者死亡率的预测。
Gastroenterology. 2011 Jun;140(7):1952-60. doi: 10.1053/j.gastro.2011.02.017. Epub 2011 Feb 18.
3
Re-weighting the model for end-stage liver disease score components.重新权衡终末期肝病评分组件的模型。
Gastroenterology. 2008 Nov;135(5):1575-81. doi: 10.1053/j.gastro.2008.08.004. Epub 2008 Aug 15.
4
Hyponatremia and mortality among patients on the liver-transplant waiting list.肝移植等待名单上患者的低钠血症与死亡率
N Engl J Med. 2008 Sep 4;359(10):1018-26. doi: 10.1056/NEJMoa0801209.
5
Inequities of the Model for End-Stage Liver Disease: an examination of current components and future additions.终末期肝病模型的不平等性：对当前组成部分及未来补充内容的审视
Curr Opin Organ Transplant. 2008 Jun;13(3):227-33. doi: 10.1097/MOT.0b013e3282ff84c7.
6
Changes in international normalized ratio (INR) and model for endstage liver disease (MELD) based on selection of clinical laboratory.基于临床实验室检查选择的国际标准化比值（INR）和终末期肝病模型（MELD）的变化。
Am J Transplant. 2007 Jun;7(6):1624-8. doi: 10.1111/j.1600-6143.2007.01822.x.
7
Different methods of creatinine measurement significantly affect MELD scores.不同的肌酐测量方法会显著影响终末期肝病模型（MELD）评分。
Liver Transpl. 2007 Apr;13(4):523-9. doi: 10.1002/lt.20994.
8
Female liver transplant recipients with the same GFR as male recipients have lower MELD scores--a systematic bias.与男性肝移植受者肾小球滤过率（GFR）相同的女性肝移植受者的终末期肝病模型（MELD）评分较低——一种系统偏差。
Am J Transplant. 2007 Mar;7(3):685-92. doi: 10.1111/j.1600-6143.2007.01666.x. Epub 2007 Jan 11.
9
Model for end-stage liver disease (MELD) exception guidelines.终末期肝病模型（MELD）例外指南
Liver Transpl. 2006 Dec;12(12 Suppl 3):S85-7. doi: 10.1002/lt.20961.
10
Model for end-stage liver disease (MELD) exception guidelines: results and recommendations from the MELD Exception Study Group and Conference (MESSAGE) for the approval of patients who need liver transplantation with diseases not considered by the standard MELD formula.终末期肝病模型（MELD）例外准则：MELD例外研究小组及会议（MESSAGE）关于批准那些患有标准MELD公式未考虑疾病而需要肝移植患者的结果与建议。
Liver Transpl. 2006 Dec;12(12 Suppl 3):S128-36. doi: 10.1002/lt.20979.
Zotero 插件